The Open Group: Hybrid Big Data Technologies Developed From €4.5M European Union Research Project Enter Final Industrial Evaluations
15.12.2020 17:00:00 EET | Business Wire | Press release
The Open Group, the vendor-neutral technology consortium, and the University of York today announced a partnership with a consortium of leading European research organizations, software developers, and industrial big data users. Together, they will make hybrid big data accessible and easy to integrate within new applications and services through developing and evolving next generation technologies.
With support from the European Union, the Polyglot and Hybrid Persistence Architectures for Big Data Analytics (TYPHON) project has already invested €4.5 million (US$5.3 million) into advanced technology development. This funding has enabled the rapid creation of applications that bridge the many formats and architectures used to store data today. The integrated platform is currently undergoing first deployments within major organizations across the Telecom, Banking, Automotive, and Aerospace industries, and is being made widely available in open source format. By implementing the new technologies, organizations are able to enhance the productivity of their data architects, reduce development time and costs, and deliver new applications and services that make full use of existing big data stores.
Today’s development teams face substantial challenges when it comes to ensuring hybrid big data applications and services are designed coherently, which requires capturing a range of different formats that data is held within. To overcome these complexities, the TYPHON project has built a set of tools for developing, querying, evolving, analyzing, and monitoring hybrid big data polystores. These polystores readily combine numerous types of underlying storage technologies, including relational, graph-based, document-based, natural language, and big data islands.
David Lounsbury, Chief Digital Officer, The Open Group said: “The TYPHON project has brought together a range of industry experts who have collaborated to streamline the time intensive process of implementing intricate big data solutions. By connecting many different storage formats, the new technologies enable developers to deliver applications capable of effectively utilizing big data assets within organizations. The Open Group has a long-standing history of working with the University of York on complex systems. Together, we can provide the expertise and guidance needed to drive these technologies through final industrial evaluations.”
The advanced tools provide big data systems developers with:
- Technologies for designing hybrid polystores, taking into account the structure of the data, the availability, partitioning, and consistency requirements of different subsets of the data, and the available deployment resources
- Novel algorithms for transforming hybrid polystore design models into preconfigured optimized virtual machines which can be deployed on cloud infrastructure
- An extensible high-level language for querying and modifying data stored in hybrid polystores, as well as capabilities for translating high-level queries into efficient native queries
- A high-performance framework for publishing and processing data access and updating events to facilitate real-time monitoring and predictive analytics
- Technologies for evolving the organization and distribution of data in hybrid polystores, along with tools for monitoring use of polystores for enhanced evolution
Coordinated by The Open Group with technical leadership from the University of York, which has directed the advanced research, the TYPHON consortium includes:
- Centrum Wiskunde & Informatica, Edge Hill University, University of L’Aquila, University of Namur: recognized leaders in their respective fields of data query languages, natural language processing, data modelling languages, and hybrid data evolution
- CLMS and SWAT Engineering: leading providers of tools and services for big data applications development
- ATB: a research institute specializing in big data deployment technologies
- Alpha Bank, GMV, OTE, and Volkswagen: industry leaders in their respective sectors - Banking, Aerospace, Telecom, and Automotive – that are undertaking final evaluations of TYPHON project technologies within their big data applications
“With the availability of the TYPHON Modelling Language, Query Language, Deployment Language, and tools for creating, monitoring, and evolving new hybrid big data polystores, software developers can now rapidly create next generation applications and systems,” said Professor Dimitris Kolovos, University of York. “Through addressing key industry challenges, the TYPHON project is dedicated to ensuring hybrid big data solutions are designed, assembled, and configured consistently - ultimately enabling organizations to unlock the power of data.”
The technological advances and innovations resulting from the TYPHON project, as well as the final versions of the technologies in open source format are publically available via the project website: www.typhon-project.org
The TYPHON project receives funding under the European Union Horizon 2020 Research and Innovation Programme, an initiative of the European Community created to foster European research and the development of new technologies, applications, and industries.
-ENDS-
About The Open Group
The Open Group is a global consortium that enables the achievement of business objectives through technology standards. Our diverse membership of more than 800 organizations includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. Further information on The Open Group can be found at www.opengroup.org.
About the University of York
The Department of Computer Science at the University of York prepares graduates for the workplace at all levels through close collaboration with industry. The majority of the research work carried out has been classed as world-leading or internationally excellent and is focused around seven themes which align our academic strengths to best meet the greater scientific, social and environmental challenges of our time. Research teams work across disciplines within academia and industry with a strong focus placed on transforming research results into tangible solutions for industry. Further information on the University of York can be found at www.cs.york.ac.uk.
# # #
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201215005656/en/
Contact information
Media Contact:
Jenny Morris
Hotwire PR (on behalf of The Open Group)
+44 (0)7393465529
UKOpengroup@hotwirepr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
